Jury still out on value of r-HGH with IVF

HELSINKI, FINLAND – Recombinant human growth hormone, or r-HGH, offered no advantage over placebo with respect to improving the live birth rate among poor-responding women undergoing in vitro...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news